scispace - formally typeset
T

Tullia Lindsten

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  93
Citations -  28566

Tullia Lindsten is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: T cell & Bcl-2 Homologous Antagonist-Killer Protein. The author has an hindex of 55, co-authored 93 publications receiving 27273 citations. Previous affiliations of Tullia Lindsten include Children's Hospital of Philadelphia & University of Michigan.

Papers
More filters
Journal ArticleDOI

Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death

TL;DR: In this article, the authors found that doubly deficient cells are resistant to multiple apoptotic stimuli that act through disruption of mitochondrial function: staurosporine, ultraviolet radiation, growth factor deprivation, etoposide, and the endoplasmic reticulum stress stimuli thapsigargin and tunicamycin.
Journal ArticleDOI

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

TL;DR: Data suggest that bcl-x plays an important role in both positive and negative regulation of programmed cell death, as well as in tissues containing long-lived postmitotic cells, such as adult brain.
Journal ArticleDOI

BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial Apoptosis

TL;DR: In mammals, BH3 domain-only molecules activate multidomain proapoptotic members to trigger a mitochondrial pathway, which both releases cytochrome c to activate caspases and initiates caspase-independent mitochondrial dysfunction.
Journal ArticleDOI

Growth factor regulation of autophagy and cell survival in the absence of apoptosis

TL;DR: Using growth factor-dependent cells from Bax/Bak-deficient mice, it is demonstrated that apoptosis is not essential to limit cell autonomous survival and growth factor signal transduction is required to direct the utilization of sufficient exogenous nutrients to maintain cell viability.